Combined VEGF gene transfer and erythropoietin in ovine reperfused myocardial infarction

International Journal of Cardiology

Volumn 165, Issue 2, 2013, Pages 291-298

  Olea, Fernanda D ^a   De Lorenzi, Andrea ^b   Cortés, Claudia ^b   Cuniberti, Luis ^a   Fazzi, Lucía ^a   Flamenco, María Del Pilar ^c   Locatelli, Paola ^a   Cabeza Meckert, Patricia ^a   Bercovich, Andrés ^d   Laguens, Rubén ^a   Crottogini, Alberto ^a  

^a FAVALORO UNIVERSITY   (Argentina)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d Bio Sidus   (Argentina)

Author keywords

Apoptosis; Erythropoietin; Gene therapy; Reperfused myocardial infarction; Sheep; VEGF

Indexed keywords

CASPASE 3; PLACEBO; RECOMBINANT ERYTHROPOIETIN; VASCULOTROPIN; ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERIOLE; ARTICLE; CAPILLARY; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; GENE EXPRESSION; GENE TRANSFER; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HEART PROTECTION; HEART WEIGHT; HEMATOLOGICAL PARAMETERS; MALE; MORTALITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REPERFUSED HEART INFARCTION; SHEEP; ANIMAL TISSUE; CORONARY ARTERY OCCLUSION; GENE DELIVERY SYSTEM; GENE THERAPY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CAPILLARY; HEART PERFUSION; HEMATOCRIT; HUMAN; OVINE MODEL; PLASMID; REPERFUSED ACUTE MYOCARDIAL INFARCTION; RISK REDUCTION; THROMBOCYTE COUNT; TRANSGENE; TREATMENT DURATION; TREATMENT RESPONSE; VEGF GENE;

ANIMALS; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; GENE TRANSFER TECHNIQUES; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; SHEEP, DOMESTIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION, LEFT;

EID: 84876670829     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.08.078     Document Type: Article

References (40)

1. W.E. Boden, K. Eagle, and C.B. Granger Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options J Am Coll Cardiol 50 2007 917 929
2. G. De Luca, H. Suryapranata, and P. Marino Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status Prog Cardiovasc Dis 50 2008 352 382
3. M.G. Sutton, and N. Sharpe Left ventricular remodeling after myocardial infarction: pathophysiology and therapy Circulation 101 2000 2981 2988
4. G. Vera Janavel, A. Crottogini, and P. Cabeza Meckert Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep Gene Ther 13 2006 1133 1142
5. G. Wright, P. Hanlon, K. Amin, C. Steenbergen, E. Murphy, and M. Arcasoy Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury FASEB J 18 2004 1031 1033
6. Z. Cai, D.J. Manalo, and G. Wei Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury Circulation 108 2003 79 85
7. L. Calvillo, R. Latini, and J. Kajstura Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling Proc Natl Acad Sci U S A 100 2003 4802 4806
8. C.J. Parsa, A. Matsumoto, and J. Kim A novel protective effect of erythropoietin in the infarcted heart J Clin Invest 112 2003 999 1007
9. A. Hirata, T. Minamino, and H. Asanuma Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts Cardiovasc Drugs Ther 19 2005 33 40
10. J.E. Baker, D. Kozik, A.K. Hsu, X. Fu, J.S. Tweddell, and G.J. Gross Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms J Cardiovasc Pharmacol 49 2007 337 345
11. F.S. Angeli, N. Amabile, and S. Burjonroppa Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction J Card Fail 16 2010 579 589
12. B.D. Westenbrink, E. Lipsic, and P. van der Meer Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization Eur Heart J 28 2007 2018 2027
13. A.F. Tramontano, R. Muniyappa, and A.D. Black Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway Biochem Biophys Res Commun 308 2003 990 994
14. M. Herrmann, H.M. Lorenz, R. Voll, M. Grünke, W. Woith, and J.R. Kalden A rapid and simple method for the isolation of apoptotic DNA fragments Nucleic Acids Res 22 1994 5506 5507
15. M.A. Quiñones, C.M. Otto, M. Stoddard, A. Waggoner, and W.A. Zoghbi Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 15 2002 167 184
16. C.L. Hansen, R.A. Goldstein, and D.S. Berman Quality Assurance Committee of the American Society of Nuclear Cardiology. Myocardial perfusion and function single photon emission computed tomography J Nucl Cardiol 13 2006 e97 e120
17. 165 gene transfer Gene Ther 9 2002 1676 1681
18. A. Crottogini, P. Cabeza Meckert, and G. Vera Janavel Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs Hum Gene Ther 14 2003 1307 1318
19. R. Laguens, P. Cabeza Meckert, and G. Vera Janavel Cardiomyocyte hyperplasia after plasmid-mediated VEGF gene transfer in pigs with chronic myocardial ischemia J Gene Med 6 2004 222 227
20. F.D. Olea, G. Vera Janavel, and A. De Lorenzi High dose erythropoietin has no long term protective effects in sheep with reperfused myocardial infarction J Cardiovasc Pharmacol 47 2006 736 741
21. A.S. Binbrek, N.S. Rao, N. Al Khaja, J. Assaqqaf, and B.E. Sobel Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction Am J Cardiol 104 2009 1035 1040
22. T. Ozawa, K. Toba, and H. Suzuki Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction. Randomized controlled pilot trial of EPO/AMI-1 study Circ J 74 2010 1415 1423
23. J.W. Suh, W.Y. Chung, and Y.S. Kim The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention Int J Cardiol 149 2 2011 Jun 2 216 220
24. R.A. Gottlieb, K.O. Burleson, R.A. Kloner, B.M. Babior, and R.L. Engler Reperfusion injury induces apoptosis in rabbit cardiomyocytes J Clin Invest 94 1994 1621 1628
25. H. Fliss, and D. Gattinger Apoptosis in ischemic and reperfused rat myocardium Circ Res 79 1996 949 956
26. H. Morimoto, M. Hirose, and M. Takahashi MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species Cardiovasc Res 78 2008 554 562
27. R.A. Gottlieb, D.L. Gruol, J.Y. Zhu, and R.L. Engler Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPasa, and apoptosis J Clin Invest 97 1996 2391 2398
28. K.A. Webster, D. Discher, S. Kaiser, O. Hernandez, B. Sato, and N.H. Bishopric Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53 J Clin Invest 104 1999 239 252
29. A. Elsasser, K. Suzuki, and J. Schaper Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure J Mol Cell Cardiol 32 2000 711 724
30. T. Scarabelli, A. Stephanou, and N. Rayment Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury Circulation 104 2001 253 256
31. A. Saraste, K. Pulkki, M. Kallajoki, K. Henriksen, M. Parvinen, and L.M. Voipio-Pulkki Apoptosis in human acute myocardial infarction Circulation 95 1997 320 323
32. G. Olivetti, F. Quaini, and R. Sala Acute myocardial infarction in human is associated with activation of programmed myocyte cell death in the surviving portion of the heart J Mol Cell Cardiol 28 1996 2005 2016
33. B. Freude, T.N. Masters, and F. Robicsek Apoptosis is initiated by myocardial ischemia and executed during reperfusion J Mol Cell Cardiol 32 2000 197 208
34. J.P. Veinot, D.A. Gattinger, and H. Fliss Early apoptosis in human myocardial infarcts Hum Pathol 28 1997 485 492
35. E. Crivellato, B. Nico, A. Vacca, V. Djonov, M. Presta, and D. Ribatti Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo Leukemia 18 2004 331 336
36. P. Locatelli, F.D. Olea, and O. Mendiz An ovine model of postinfarction dilated cardiomyopathy in animals with highly variable coronary anatomy ILAR J 52 2011 e16 e21
37. J. Kastrup, E. Jørgensen, and A. Rück Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial J Am Coll Cardiol 45 2005 982 988
38. S. Fuchs, N. Dib, and B.M. Cohen A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease Catheter Cardiovasc Interv 68 2006 372 378
39. D.J. Stewart, M.J. Kutryk, and D. Fitchett VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial Mol Ther 17 2009 1109 1115
40. L. Favaloro, M. Diez, and O. Mendiz High-dose plasmid VEGF gene transfer in patients with severe coronary artery disease. Six-months and preliminary 2-year results of the first Latin American trial of gene therapy in myocardial ischemia Eur Heart J 31 abstr suppl. 2010 488 (abstract P2982)